PCVX
insider transactionsVaxcyte, Inc. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Net shares · 90d
-43.2K
0 buy · 43.2K sell
Net value · 90d
-$2.3M
$0 in · $2.3M out
Sentiment · 90d
Net selling
0% buying · 100% selling
Open-market trades · 90d
10
0 buy · 43.2K sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Exercise·M
Grant Pickering KEY
CHIEF EXECUTIVE OFFICER · 10b5-1
$0
225 sh
Own New
-
Sell·S
Grant Pickering KEY
CHIEF EXECUTIVE OFFICER · 10b5-1
$52.5K
1.0K sh · $52.50
Own -1%
-
Sell·S
Grant Pickering KEY
CHIEF EXECUTIVE OFFICER · 10b5-1
$1.2M
22.2K sh · $52.50
Own -4%
-
Sell·S
Grant Pickering KEY
CHIEF EXECUTIVE OFFICER · 10b5-1
$11.8K
225 sh · $52.51
Own -0%
-
Exercise·M
Grant Pickering KEY
CHIEF EXECUTIVE OFFICER · 10b5-1
$403
225 sh · $1.79
Own +0%
-
Exercise·M
PRESIDENT AND CFO · 10b5-1
$0
10.0K sh
Own +4%
-
Sell·S
PRESIDENT AND CFO · 10b5-1
$530.0K
10.0K sh · $53.00
Own -9%
-
Exercise·M
PRESIDENT AND CFO · 10b5-1
$53.5K
10.0K sh · $5.35
Own +10%
-
Grant·A
Director
$0
11.4K sh
Own New
-
Grant·A
Director
$0
2.3K sh
Own +49%
-
Grant·A
Director
$0
11.4K sh
Own New
-
Grant·A
Director
$0
2.3K sh
Own +13%
-
Grant·A
Director
$0
11.4K sh
Own New
-
Grant·A
Director
$0
2.3K sh
Own +22%
-
Grant·A
Director
$0
11.4K sh
Own New
-
Grant·A
Director
$0
2.3K sh
Own +49%
-
Grant·A
Director
$0
11.4K sh
Own New
-
Grant·A
Director
$0
2.3K sh
Own +22%
-
Grant·A
Director
$0
11.4K sh
Own New
-
Grant·A
Director
$0
2.3K sh
Own +74%
-
Grant·A
Director
$0
11.4K sh
Own New
-
Grant·A
Director
$0
2.3K sh
Own +22%
-
Sell·S
CHIEF OPERATING OFFICER · 10b5-1
$15.1K
301 sh · $50.26
Own -0%
-
Sell·S
CHIEF OPERATING OFFICER · 10b5-1
$96.3K
1.9K sh · $49.40
Own -1%
-
Sell·S
CHIEF OPERATING OFFICER · 10b5-1
$127.9K
2.2K sh · $56.83
Own -1%
-
Exercise·M
SVP, Finance & CAO · 10b5-1
$0
3.0K sh
Own +3%
-
Sell·S
SVP, Finance & CAO · 10b5-1
$180.0K
3.0K sh · $60.00
Own -9%
-
Exercise·M
SVP, Finance & CAO · 10b5-1
$77.8K
3.0K sh · $25.92
Own +10%
-
Sell·S
CHIEF OPERATING OFFICER · 10b5-1
$49.4K
838 sh · $58.93
Own -1%
-
Sell·S
CHIEF OPERATING OFFICER · 10b5-1
$82.1K
1.4K sh · $58.14
Own -1%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 18, 2026 | Grant Pickering KEY 10b5-1 | Exercise M | 225 | $0 |
| Jun 18, 2026 | Grant Pickering KEY 10b5-1 | Sell S | 1.0K | $52.5K |
| Jun 18, 2026 | Grant Pickering KEY 10b5-1 | Sell S | 22.2K | $1.2M |
| Jun 18, 2026 | Grant Pickering KEY 10b5-1 | Sell S | 225 | $11.8K |
| Jun 18, 2026 | Grant Pickering KEY 10b5-1 | Exercise M | 225 | $403 |
| Jun 18, 2026 | Andrew Guggenhime KEY 10b5-1 | Exercise M | 10.0K | $0 |
| Jun 18, 2026 | Andrew Guggenhime KEY 10b5-1 | Sell S | 10.0K | $530.0K |
| Jun 18, 2026 | Andrew Guggenhime KEY 10b5-1 | Exercise M | 10.0K | $53.5K |
| Jun 15, 2026 | Carlos V Paya | Grant A | 11.4K | $0 |
| Jun 15, 2026 | Carlos V Paya | Grant A | 2.3K | $0 |
| Jun 15, 2026 | Heath Lukatch | Grant A | 11.4K | $0 |
| Jun 15, 2026 | Heath Lukatch | Grant A | 2.3K | $0 |
| Jun 15, 2026 | Teri Loxam | Grant A | 11.4K | $0 |
| Jun 15, 2026 | Teri Loxam | Grant A | 2.3K | $0 |
| Jun 15, 2026 | Jacks Lee | Grant A | 11.4K | $0 |
| Jun 15, 2026 | Jacks Lee | Grant A | 2.3K | $0 |
| Jun 15, 2026 | Halley E Gilbert | Grant A | 11.4K | $0 |
| Jun 15, 2026 | Halley E Gilbert | Grant A | 2.3K | $0 |
| Jun 15, 2026 | John Furey | Grant A | 11.4K | $0 |
| Jun 15, 2026 | John Furey | Grant A | 2.3K | $0 |
| Jun 15, 2026 | Anne S Drapeau | Grant A | 11.4K | $0 |
| Jun 15, 2026 | Anne S Drapeau | Grant A | 2.3K | $0 |
| Jun 1, 2026 | Jim Wassil 10b5-1 | Sell S | 301 | $15.1K |
| Jun 1, 2026 | Jim Wassil 10b5-1 | Sell S | 1.9K | $96.3K |
| May 1, 2026 | Jim Wassil 10b5-1 | Sell S | 2.2K | $127.9K |
| Apr 7, 2026 | Elvia Cowan 10b5-1 | Exercise M | 3.0K | $0 |
| Apr 7, 2026 | Elvia Cowan 10b5-1 | Sell S | 3.0K | $180.0K |
| Apr 7, 2026 | Elvia Cowan 10b5-1 | Exercise M | 3.0K | $77.8K |
| Apr 1, 2026 | Jim Wassil 10b5-1 | Sell S | 838 | $49.4K |
| Apr 1, 2026 | Jim Wassil 10b5-1 | Sell S | 1.4K | $82.1K |
About PCVX insider trading
This page tracks insider transactions for Vaxcyte, Inc. (PCVX) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.